News from hcplive.comFollowNews from hcplive.comSee all of hcplive.com news coverage in one place. Discover how hcplive.com’s media bias informs their coverage and compare with thousands of other news outlets.Ground News has come across 327 headlines reported on by hcplive.com during the past 3 months. hcplive.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is hcplive.com credible or reliable? Our Factuality score answers both of those questions. When it comes to hcplive.com, we’ve assigned a unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.Follow See all of hcplive.com news coverage in one place. Discover how hcplive.com’s media bias informs their coverage and compare with thousands of other news outlets. Ground News has come across 327 headlines reported on by hcplive.com during the past 3 months. hcplive.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is hcplive.com credible or reliable? Our Factuality score answers both of those questions. When it comes to hcplive.com, we’ve assigned a unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check. Information about hcplive.comWhere is hcplive.com located?hcplive.com's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top hcplive.com NewsDiabetes · ChinaDrinking 1 to 3 cups of coffee a day may protect heart health, new study finds79% Center coverage: 39 sourcesA morning cup of coffee may do more than just perk you up, according to new research. Moderate amounts of caffeine intake — defined as one to three cups of coffee or tea a day — were associated with a lower risk of developing cardiometabolic multimorbidity, said the study’s lead author, Dr. Chaofu Ke, associate professor of epidemiology and biostatistics at Soochow University in Suzhou, China. See the StoryBusiness · United StatesFDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades50% Center coverage: 30 sourcesThe Food and Drug Administration on Thursday approved Bristol Myers Squibb’s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades. See the StoryStock Markets · United StatesDupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD) - Regeneron Pharmaceuticals (NASDAQ:REGN)67% Center coverage: 3 sourcesApproval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life COPD is the most prevalent chronic respiratory disease in China, and is a priority within the government's Healthy China 2030 public health plan Dupixent is now approved in four indicat…See the StoryLatest News StoriesTopics Most Covered by hcplive.comHealthFDAMedicalDiabetesArtificial IntelligenceHealthFDAMedicalSources Covering Similar TopicsMedPage Todaystocktitan.netajmc.compipelinereviewMedical XpressMedPage Todaystocktitan.netajmc.comSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.Breaking News Topics Related to hcplive.comCalifornia, United StatesHealthMarylandSan Francisco, CaliforniaSan Diego CountySan DiegoSan Francisco CountyUnited States
